Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray

키워드

참고문헌 (35)

1. Perz JF, "The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide", J Hepatol, 45, pp.529~538 (2006)[DOI]
2. Schiff ER, "Prevention of mortality from hepatitis B and hepatitis C", Lancet, 368, pp.896~897 (2006)[DOI]
3. Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)[DOI]
4. Liaw YF, "Lamivudine for patients with chronic hepatitis B and advanced liver disease", N Engl J Med, 351, pp.1521~1531 (2004)[DOI]
5. Hoofnagle JH, "Management of hepatitis B: summary of a clinical research workshop", Hepatology, 45, pp.1056~1075 (2007)[DOI]
6. Zoulim F, "Hepatitis B virus resistance to nucleos(t)ide analogues", Gastroenterology, 137, pp.1593~1608 (2009)[DOI]
7. Yim HJ, "Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade", Clin Mol Hepatol, 19, pp.195~209 (2013)[DOI]
8. Lee JH, "Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance", Antimicrob Agents Chemother, 58, pp.1730~1737 (2014)[DOI]
9. Ou ZY, "Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method", J Clin Microbiol, 43, pp.5685~5689 (2005)[DOI]
10. Whalley SA, "Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler", J Clin Microbiol, 39, pp.1456~1459 (2001)[DOI]
11. Libbrecht E, "Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay", J Clin Microbiol, 45, pp.3935~3941 (2007)[DOI]
12. Lindstrom A, "Pyrosequencing for detection of lamivudine-resistant hepatitis B virus", J Clin Microbiol, 42, pp.4788~4795 (2004)[DOI]
13. Kirishima T, "Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment", J Hepatol, 37, pp.259~265 (2002)[DOI]
14. Jang H, "Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus", J Clin Microbiol, 42, pp.4181~4188 (2004)[DOI]
15. Hong SP, "Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments", J Hepatol, 40, pp.837~844 (2004)[DOI]
16. Lee CH, "Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough", Gastroenterology, 130, pp.1144~1152 (2006)[DOI]
17. Kim JH, "Molecular diagnosis and treatment of drug-resistant hepatitis B virus", World J Gastroenterol, 20, pp.5708~5720 (2014)[DOI]
18. Heo Jeong, "Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection", Journal of Korean Medical Science, 19(4), pp.541~546 (2004), 대한의학회
19. Vernet G, "The DNA-Chip technology as a new molecular tool for the detection of HBV mutants", J Clin Virol, 34(Suppl 1), pp.S49~S53 (2005)[DOI]
20. Pas SD, "Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus", J Clin Microbiol, 46, pp.1268~1273 (2008)[DOI]
21. Kwon SH, "DNA-DNA interaction on dendron-functionalized sol-gel silica films followed with surface plasmon fluorescence spectroscopy", J Colloid Interface Sci, 308, pp.325~331 (2007)[DOI]
22. Hong BJ, "Nanoscale-controlled spacing provides DNA microarrays with the SNP discrimination efficiency in solution phase", Langmuir, 21, pp.4257~4261 (2005)[DOI]
23. Hong BJ, "DNA microarrays on nanoscalecontrolled surface", Nucleic Acids Res, 33, pp.e106~ (2005)[DOI]
24. Oh SJ, "DNA microarrays on a dendron-modified surface improve significantly the detection of single nucleotide variations in the p53 gene", Nucleic Acids Res, 33, pp.e90~ (2005)[DOI]
25. Lim KH, "Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of TRIM22", Gut, 67, pp.166~178 (2018)[DOI]
26. Park YK, "Cleaved c-FLIP mediates the antiviral effect of TNF-alpha against hepatitis B virus by dysregulating hepatocyte nuclear factors", J Hepatol, 64, pp.268~277 (2016)[DOI]
27. Kim KT, "Dramatic increase in signal by integration of polymerase chain reaction and hybridization on surface of DNA microarray", Anal Biochem, 396, pp.139~145 (2010)[DOI]
28. Tjong V, "Amplified on-chip fluorescence detection of DNA hybridization by surfaceinitiated enzymatic polymerization", Anal Chem, 83, pp.5153~5159 (2011)[DOI]
29. Klein A, "Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences", J Clin Microbiol, 35, pp.1897~1899 (1997)
30. Kim JH, "Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment", Hepatology, 66, pp.335~343 (2017)[DOI]
31. Caligiuri P, "Overview of hepatitis B virus mutations and their implications in the management of infection", World J Gastroenterol, 22, pp.145~154 (2016)[DOI]
32. Kim KH, "Discovery and development of anti-HBV agents and their resistance", Molecules, 15, pp.5878~5908 (2010)[DOI]
33. Ahn SH, "The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene", J Virol, 88, pp.6805~6818 (2014)[DOI]
34. Corsa AC, "No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B", Clin Gastroenterol Hepatol, 12, pp.2106~2112 (2014)[DOI]
35. 정고은, "Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)idenaïve patients", Clinical and Molecular Hepatology, 23(1), pp.66~73 (2017), 대한간학회[DOI]

관련 논문AI추천